INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLSPRNewsWire · 2 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLSGlobeNewsWire · 4 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLSPRNewsWire · Oct 15, 2026
Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration ProgramBusiness Wire · Oct 14, 2026
EOLS Investors with $100,000 in Losses Have Opportunity to Join Evolus, Inc. Fraud Investigation with SBS LawGuruFocus · Oct 12, 2026
EOLS Investors with $100,000 in Losses Have Opportunity to Join Evolus, Inc. Fraud Investigation with SBS LawBusiness Wire · Oct 12, 2026Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 5, 2026 | -$0.03 | $0.01 | Beat |
| May 4, 2026 | -$0.14 | -$0.10 | Beat |
| Mar 3, 2026 | $0.06 | $0.04 | Miss |
| Nov 5, 2025 | -$0.19 | -$0.14 | Beat |
| Aug 5, 2025 | -$0.09 | -$0.24 | Miss |
| May 7, 2025 | -$0.10 | -$0.18 | Miss |